Oestrogen and protection against cardiovascular disease: Potential versus reality

British Journal of Cardiology

Volumn 8, Issue 6, 2001, Pages

  Poulter, N ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiovascular risk; Coronary heart disease; Hormone replacement therapy; Oestrogen

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL OBSERVATION; DISEASE ASSOCIATION; ESTROGEN ACTIVITY; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSE; MORTALITY; PREDICTION; REVIEW; RISK FACTOR;

EID: 0034936198     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Sex hormones and coronary disease: A review of the clinical studies
2. Hormone replacement therapy, heart disease, and other considerations
3. Newer oral contraceptives and the risk of venous thromboembolism
4. Stroke and steroid hormonal contraception
5. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study
6. Oral contraceptives and blood pressure
7. Blood coagulation and oral contraceptives
8. Hormonal contraception and risk of cardiovascular disease
9. Migraine and stroke in young women: A case-control study
10. Estrogen and coronary heart disease in women
11. Are gonadal hormones (estrogens and androgens) of significance in the development of ischemic heart disease?
12. Myth and paradox of coronary heart risk and the menopause
13. Hormone replacement therapy
14. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
15. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials